Abstract
Coronary artery disease (CAD) commonly occurs and elevates the risk of cardiovascular events and mortality in chronic kidney disease (CKD) patients. The underlying pathogenesis of CKD-related CAD is believed to be closely linked to inflammatory responses. Here, we explored inflammation-related markers for early diagnosis and management of CAD in CKD patients. Through comprehensive bioinformatics analysis and machine learning techniques, glutamate cysteine ligase modifier subunit (GCLM), nuclear protein 1 (NUPR1), and prostaglandin E receptor 1 (PTGER1) were selected as hub biomarkers. Furthermore, GCLM and NUPR1 were demonstrated significantly upregulated in the two validation cohorts of CKD patients with or without hemodialysis, while the change in PTGER1 was not prominent. Additionally, GCLM and NUPR1 were identified as promising indicators to predict CAD in CKD patients. Our study deciphered the higher predictive genes for CAD associated with CKD that is related to inflammation, which provides novel insights into the diagnosis and therapeutic options.